Bayer Denied Fees After $155M Hemophilia Drug IP Verdict
A Delaware federal judge on Monday shot down Bayer's bid to collect attorney fees in a case against a Takeda Pharmaceutical unit, though the company did win additional damages on top...To view the full article, register now.
Already a subscriber? Click here to view full article